Biological age vs vascular age: which age metric matters most?
Longevity · Updated

Biological age vs vascular age: which age metric matters most?

Biological age and vascular age sound similar — but they measure different things. Here's how they compare, when each matters, and which to track.

#biological age #vascular age #arterial stiffness #pulse wave velocity #cardiovascular aging #longevity

You can have a 50-year-old body and 70-year-old arteries — or the other way around. The two systems age on overlapping but distinct timelines, and lumping them together under “biological age” obscures one of the most actionable signals in cardiovascular medicine.

If you’ve ever read a longevity report that mentioned both biological age and vascular age, you’ve probably wondered whether they’re the same thing dressed up in different language. They aren’t. They measure related but separate things, and confusing them leads to bad tracking decisions — like treating arterial stiffness as a downstream side effect of aging instead of the early-warning system it actually is.

This guide breaks down exactly how biological age and vascular age differ, what each one captures, when one matters more than the other, and how to use both to make better decisions about cardiovascular risk and healthspan.

What you’ll learn:

  • How biological age and vascular age are defined and measured
  • Where the two metrics agree and where they diverge
  • When each one is the better signal to act on
  • How to track both without buying clinical equipment

Quick definition

If you’ve ever read a longevity report that mentioned both biological age and vascular age, you’ve probably wondered whether they’re the same thing dressed up in different language. They aren’t. They measure related but separate things, and confusing them leads to bad tracking decisions — like treating arterial stiffness as a downstream side effect of aging instead of the early-warning system it actually is.

Key takeaways

  • Different metrics, different jobs: biological age is a whole-body composite; vascular age is artery-specific.
  • Vascular age is the faster indicator: arterial stiffness responds to exercise and lifestyle changes within weeks; biological age clocks usually need months to register the same signal.
  • They can diverge significantly: you can have aging arteries with okay whole-body biomarkers, or the reverse — and that divergence is itself useful information.
  • Track both for full coverage: biological age for healthspan breadth, vascular age for cardiovascular risk specifically.
  • Vascular age catches problems early: arterial stiffening shows up before blood pressure climbs and decades before clinical events.

What is biological age?

Biological age is an estimate of how old your body is functioning, regardless of what your birthday says. It’s calculated from biomarkers — typically blood markers and physiological measurements — that change predictably with aging across populations.

Quick definition: Biological age is a composite score derived from biomarkers like albumin, glucose, creatinine, inflammation markers, and others, designed to estimate the body’s overall functional age compared to a reference population.

The most studied biological age clocks include PhenoAge (developed by Levine and colleagues), KDM (Klemera-Doubal Method), and epigenetic clocks like Horvath’s, GrimAge, and DunedinPACE. These differ in inputs and methodology, but they share a core property: they estimate whole-body functional aging, integrating signals from multiple organ systems into a single number.

What biological age tells you

A biological age higher than your chronological age means your biomarkers look worse than the average person your calendar age. It’s a coarse but powerful signal — strong enough to predict mortality risk in large epidemiological studies. The reverse is also true: someone with a biological age 8 years lower than their chronological age has, on average, lower all-cause mortality risk.

What it doesn’t tell you is where the aging is happening. A bad PhenoAge score could be driven by inflammation, kidney decline, glucose dysregulation, or any combination — the score itself is a summary, not a diagnosis.


What is vascular age?

Vascular age is the functional age of your arteries — specifically, how stiff they’ve become and how efficiently they transmit blood pressure waves. It’s an organ-specific metric, not a whole-body one.

Quick definition: Vascular age is an estimate of how old your arteries appear based on their stiffness, typically measured by pulse wave velocity (PWV) and compared to age-stratified reference values.

The gold standard measurement is carotid-femoral pulse wave velocity (cfPWV) — the time it takes for a pressure wave to travel between the carotid and femoral arteries. Stiffer arteries propagate the wave faster, so a higher PWV means older-acting arteries. PWV is non-invasive, well-validated, and predictive of cardiovascular events independent of standard risk factors.

What vascular age tells you

Unlike biological age, vascular age is laser-focused: it tells you about the structural and functional state of your arteries. That matters because arterial stiffness is one of the earliest detectable signs of cardiovascular aging — it shows up before blood pressure climbs, before plaque becomes visible on imaging, and decades before clinical events.

Two key drivers of arterial stiffness:

  • Elastin fragmentation and collagen accumulation in the arterial wall, reducing compliance
  • Endothelial dysfunction, which impairs the vessels’ ability to dilate appropriately

Both are reversible to varying degrees with the right interventions, which is why vascular age is one of the most actionable longevity metrics available.


How they’re measured

Aspect Biological age Vascular age
Primary inputs Blood biomarkers (PhenoAge: albumin, creatinine, glucose, hs-CRP, WBC, lymphocytes, MCV, RDW, alkaline phosphatase, age) or epigenetic methylation patterns Pulse wave velocity (cfPWV gold standard) or estimated PWV from blood pressure + age
Where it’s measured Standard blood draw or saliva/blood DNA test Specialized device (tonometer, oscillometric cuff) — some smart scales estimate it
What it summarizes Whole-body functional aging across multiple organ systems Arterial stiffness specifically
Cost (USD) $50–500 (blood) or $150–500 (epigenetic) $0 if estimated by formula, $200–500 for direct PWV measurement
Repeat frequency Every 6–12 months Every 6–12 months for trend, more frequently if intervening

Estimated vs measured PWV

A practical note: many consumer devices report a “vascular age” derived from blood pressure, heart rate, and chronological age using regression formulas. These estimated PWV scores correlate with measured PWV but are not the same thing — they’re a population-level proxy. Direct PWV measurement remains the standard for clinical and research use.


Where biological age and vascular age overlap

The two metrics aren’t independent. Several biological pathways drive both whole-body aging and arterial stiffness simultaneously:

  • Chronic inflammation (measurable as elevated hs-CRP, IL-6, TNF-α) accelerates both biomarker-based biological age and endothelial dysfunction
  • Insulin resistance and metabolic dysfunction appear in PhenoAge inputs (glucose) and also drive vascular stiffening through advanced glycation end products
  • Oxidative stress contributes to mitochondrial dysfunction (whole-body aging) and to elastin breakdown (vascular aging)
  • Sedentary behavior worsens both

Empirically, large cohort studies have found that elevated PWV correlates with elevated biological age clocks. People with “old” arteries also tend to have “old” biology by composite scores, and vice versa. The correlation is real but moderate — typically r = 0.3 to 0.5, depending on the study and clocks used.


Where they diverge

The correlation isn’t perfect because the two metrics weight different organ systems and respond to different interventions on different timescales.

Diverge case 1: arteries age first

Some people have above-average arterial stiffness years before their composite biological age looks unusual. This is common in:

  • People with chronic high blood pressure (even untreated mild hypertension)
  • Long-term smokers, even before lung function shows decline
  • People with type 2 diabetes — vascular damage often outpaces other organ aging
  • Genetic predisposition to arterial stiffness (familial patterns)

In these cases, vascular age is the leading indicator. By the time PhenoAge looks bad, the arteries have been telling the same story for a decade.

Diverge case 2: arteries stay young

Conversely, some people have biomarker profiles that suggest accelerated whole-body aging (poor kidney function, chronic inflammation, glucose dysregulation) but relatively preserved arterial stiffness. This pattern shows up in:

  • People with autoimmune conditions affecting non-vascular organs
  • Anemia or chronic kidney disease patients without secondary hypertension
  • Lean, normotensive people with metabolic dysfunction

Here, biological age is the leading signal — vascular consequences may follow but haven’t yet.

Diverge case 3: intervention timing

Aerobic exercise improves arterial stiffness within 4–12 weeks in controlled studies — measurable PWV reductions appear quickly. But composite biological age clocks often need 6–12 months to register the same effect, because they depend on slower-moving biomarkers like albumin and creatinine.

If you’re tracking the impact of a new training protocol or dietary change, vascular age responds faster.


Which should you track?

This is where the comparison becomes practical. The honest answer: both, but for different reasons.

Track biological age when:

  • You want a single composite metric for overall healthspan
  • You’re already getting routine blood work and want to extract more value from it
  • You’re optimizing across multiple organ systems (kidney, liver, metabolism, immune)
  • You’re early in a longevity protocol and want a stable, integrated baseline

Track vascular age when:

  • You have cardiovascular risk factors (hypertension, diabetes, family history)
  • You want a fast-response metric for evaluating exercise or diet changes
  • You’re focused specifically on cardiovascular healthspan
  • You’ve had a borderline lipid panel and want a functional read on artery health

Decision framework

Goal Prioritize
Overall healthspan tracking Biological age (PhenoAge or DunedinPACE)
Early cardiovascular warning Vascular age (PWV)
Evaluating an intervention Vascular age (responds faster)
Annual longevity dashboard Both — they answer different questions
Limited budget, one metric Biological age — broader signal
Existing cardiovascular concerns Vascular age — organ-specific

How SuperAge connects both signals

Tracking biological age and vascular age in parallel is the kind of work that traditionally requires a clinical team and multiple specialized tests. SuperAge simplifies this by integrating wearable signals, manual blood test inputs, and validated formulas into one continuous picture:

Biological age, calculated from your data

SuperAge computes a biological age score from biomarkers you enter (PhenoAge inputs from routine blood work) plus wearable-derived signals like resting heart rate, HRV, and activity load. You see a single composite number trending over time, with the underlying drivers visible — so you can tell whether a change is driven by inflammation, metabolic markers, or kidney function.

Vascular signals from your wearable

While direct PWV requires specialized equipment, SuperAge surfaces vascular-aging-adjacent signals from your Apple Watch and Apple Health data: blood pressure trends if you log them, heart rate recovery, and resting heart rate. These don’t replace clinical PWV, but they give you continuous trend data that catches changes weeks before a single clinic visit would.

One dashboard for cardiovascular healthspan

You see how lifestyle changes — added zone 2 exercise, dietary shifts, stress management — affect both your composite biological age and the cardiovascular markers feeding into it. The two metrics stop being abstract and start informing concrete decisions.


Frequently asked questions

Is vascular age the same as biological age?

No. Vascular age is an organ-specific metric measuring arterial stiffness, while biological age is a whole-body composite derived from biomarkers spanning multiple organ systems. They correlate moderately but capture different aspects of aging — and they can diverge significantly in individuals.

Can vascular age be lower than chronological age?

Yes. People with consistently low blood pressure, high cardiovascular fitness, healthy weight, low inflammation, and good metabolic health often have vascular ages 5–15 years lower than their chronological age. Sustained aerobic training is one of the most robust predictors of “young” arteries at any chronological age.

Which improves faster with exercise — biological age or vascular age?

Vascular age. Aerobic training reduces arterial stiffness within 4–12 weeks in controlled trials, measurable as PWV improvements. Composite biological age clocks usually need 6–12 months to register the same effect because they depend on slower-changing biomarkers.

Do I need a hospital test to measure vascular age?

The gold standard cfPWV measurement requires specialized equipment, but reasonable estimates exist. Some smart scales and consumer devices report “vascular age” estimates from blood pressure and heart rate. These are population-level proxies — useful for trends but not equivalent to direct PWV.

Should younger adults care about vascular age?

Yes — possibly more than older adults. Vascular changes start in the 30s and accelerate after 50. Catching arterial stiffening in the 30s or 40s gives you a long runway to reverse it through lifestyle interventions, while the same finding at 70 may have already produced clinical consequences.


Key takeaways

  • Different metrics, different jobs: biological age is a whole-body composite; vascular age is artery-specific.
  • Vascular age is the faster indicator: arterial stiffness responds to exercise and lifestyle changes within weeks; biological age clocks usually need months to register the same signal.
  • They can diverge significantly: you can have aging arteries with okay whole-body biomarkers, or the reverse — and that divergence is itself useful information.
  • Track both for full coverage: biological age for healthspan breadth, vascular age for cardiovascular risk specifically.
  • Vascular age catches problems early: arterial stiffening shows up before blood pressure climbs and decades before clinical events.

Track the metrics that matter

The two ages aren’t competitors — they’re complementary signals telling you different things about how your body is aging. Use both, weight them by your goals, and watch the trends rather than single readings.

Ready to see both? Download SuperAge (App Store) and start tracking biological age, cardiovascular signals, and the lifestyle factors that move both.


References

  1. Mitchell GF, et al. Arterial stiffness, pressure and flow pulsatility, and brain structure and function: the Age, Gene/Environment Susceptibility — Reykjavik Study. Brain. https://pmc.ncbi.nlm.nih.gov/articles/PMC3212721/
  2. Levine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC5940111/
  3. Townsend RR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. https://pubmed.ncbi.nlm.nih.gov/26160955/
  4. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2009.10.061
  5. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Circulation. https://pubmed.ncbi.nlm.nih.gov/12515756/
  6. Determinants of Vascular Age: An Epidemiological Perspective. PMC6503857. https://pmc.ncbi.nlm.nih.gov/articles/PMC6503857/
  7. Update on the Use of Pulse Wave Velocity to Measure Age-Related Vascular Changes. PMC10955453. https://pmc.ncbi.nlm.nih.gov/articles/PMC10955453/

Last updated: 2026-06-07. This article is regularly reviewed to ensure accuracy. The information provided does not replace professional medical advice. Consult your healthcare provider for personalized cardiovascular risk assessment.

Written by SuperAge Team

The SuperAge Team writes evidence-informed guides on biological age, longevity biomarkers, Apple Health, wearables, and practical healthspan tracking.